Kathleen Belien graduated in 1989 as MSc in Pharmaceutical sciences at the KU Leuven. She worked as a Clinical Research Associate and project coordinator in clinical research in various domains. Since ten years she is study coordinator of the Thoracic Oncology Group Antwerp, an interdisciplinary centre of expertise in thoracic malignancies at the University of Antwerp. Current doctoral research project focuses on the diagnostic phase of lung cancer. This research is a collaboration of the Thoracic Oncology Group Antwerp and the End-of-Life Care Research Group at the VUB.